MaxLinear, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation and Employee Benefit Plans (Tables)

Stock-Based Compensation and Employee Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2012

The fair values of stock options and employee stock purchase rights were estimated at their respective grant date using the following assumptions:

Stock Options


	Nine Months Ended September 30,
	2012			2011
Weighted-average grant date fair value per share	$	2.37		$	4.26
Risk-free interest rate		0.88	%		2.01	%
Dividend yield		—			—
Expected life (years)		4.84			5.05
Volatility		55.91	%		51.83	%

Fair Value of Employee Stock Purchase Rights

Employee Stock Purchase Rights

	Nine Months Ended September 30,
	2012			2011
Weighted-average grant date fair value per share	$	1.28		$	2.46
Risk-free interest rate		0.15	%		0.07	%
Dividend yield		—			—
Expected life (years)		0.50			0.50
Volatility		46.60	%		45.70	%

Stock-Based Compensation

The Company recognized stock-based compensation in the statements of operations as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Cost of net revenue	$	23	$	15	$	61	$	38
Research and development		1,661		1,308		4,590		3,014
Selling, general and administrative		925		846		2,514		2,154

	$	2,609	$	2,169	$	7,165	$	5,206

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References + Details